Evidence map›Paper›PMID 31311877›Full record

ArticlemBio2019

Lamba Omar Sangaré, Ninghan Yang, Eleni K Konstantinou, Diana Lu, Debanjan Mukhopadhyay, Lucy H Young, Jeroen P J Saeij

Open access · goldAbstract read
In one paragraph

Article in mBio, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 82 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. A Suite of EightbioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Dense granule proteins: key mediators ofFrontiers in medicine · 2026
    Review
  7. Cysteine-S-nitrosylation inhibits Rop5-mediated immune evasion inbioRxiv : the preprint server for biology · 2025
    Article
  8. Article
  9. GRK2 activates TRAF2-NF-Acta pharmaceutica Sinica. B · 2025
    Article
  10. Review
  11. mBio · 2024
    Article
  12. Toxoplasma gondii IgG Serointensity Is Positively Associated With Frailty.The journals of gerontology. Series A, Biological sciences and medical sciences · 2024
    Article
  13. Vaccines · 2024
    Article
  14. Article
  15. Review
  16. ThemSphere · 2023
    Article
  17. Article
  18. Article
  19. A novelFrontiers in microbiology · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Lamba Omar Sangaré *School of Veterinary Medicine, Department of Pathology, Microbiology and Immunology, University of California Davis, Davis, California, USA.
Ninghan Yang *Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Eleni K KonstantinouDepartment of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA.
Diana LuDepartment of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Debanjan MukhopadhyaySchool of Veterinary Medicine, Department of Pathology, Microbiology and Immunology, University of California Davis, Davis, California, USA.
Lucy H YoungDepartment of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA.
Jeroen P J SaeijSchool of Veterinary Medicine, Department of Pathology, Microbiology and Immunology, University of California Davis, Davis, California, USA jsaeij@ucdavis.edu.ORCID 0000-0003-0289-7109
University of California, Davis · USHarvard University · USMassachusetts Institute of Technology · US

Funding

PRE-DOCTORAL TRAINING IN THE BIOLOGICAL SCIENCEST32GM007287 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BELL, STEPHEN P., KEATING, AMY E · 1985 to 2019
$40.8M
Toxoplasma strain-specific modulation of mouse immune cellsR01AI080621 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI SAEIJ, JEROEN · 2009 to 2018
$3.6M
NIAID NIH HHS R01 AI080621NIGMS NIH HHS T32 GM007287
6 · The paper itself

Abstract

The protozoan parasite

Indexed as

Signal TransductionBinding SitesGene ExpressionHost-Pathogen InteractionsHumansNF-kappa BProtein BindingProtozoan ProteinsToxoplasmaToxoplasmosisTumor Necrosis Factor Receptor-Associated Peptides and ProteinsNF-kappa BProtozoan ProteinsTumor Necrosis Factor Receptor-Associated Peptides and Proteinshost-pathogen interactionsNF-κB pathwayToxoplasma gondiiTRAF2TRAF6

Identifiers

PMID31311877
PMCPMC6635525
OpenAlexW2956327078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.